Human camp-dependent protein kinase inhibitor homolog
US5648239A · kind A · utility
10Cited by
0References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 21, 1996 |
| Grant date | Jul 15, 1997 |
| Priority date | — |
| Expiry date | Jun 21, 2016 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a polynucleotide (ipka) which identifies and encodes a novel human cAMP-dependent protein kinase A inhibitor homolog (IPKA). The invention provides for genetically engineered expression vectors and host cells comprising the nucleic acid sequence encoding IPKA.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.